AAAAAA

   
Results: 1-8 |
Results: 8

Authors: Kaplan, KM
Citation: Km. Kaplan, Weight and happiness, ARCH PED AD, 155(4), 2001, pp. 525-525

Authors: Markey, P Krause, V Boslego, JW Coplan, PM Dargan, JM Kaplan, KM
Citation: P. Markey et al., The effectiveness of Haemophilus influenzae type b conjugate vaccines in ahigh risk population measured using immunization register data, EPIDEM INFE, 126(1), 2001, pp. 31-36

Authors: Linglof, T van Hattum, J Kaplan, KM Corrigan, J Duval, I Jensen, E Kuter, B
Citation: T. Linglof et al., An open study of subcutaneous administration of inactivated hepatitis A vaccine (VAQTA((R))) in adults: safety, tolerability, and immunogenicity (vol19, pg 3968, 2001), VACCINE, 20(1-2), 2001, pp. 281-281

Authors: Hornick, R Tucker, R Kaplan, KM Eves, KA Banerjee, D Jensen, E Kuter, B
Citation: R. Hornick et al., A randomized study of a flexible booster dosing regimen of VAQTA (R) in adults: safety, tolerability, and immunogenicity, VACCINE, 19(32), 2001, pp. 4727-4731

Authors: Linglof, T van Hattum, J Kaplan, KM Corrigan, J Duval, I Jensen, E Kuter, B
Citation: T. Linglof et al., An open study of subcutaneous administration of inactivated hepatitis A vaccine (VAQTA((R))) in adults: safety, tolerability, and immunogenicity, VACCINE, 19(28-29), 2001, pp. 3968-3971

Authors: Vessey, SJR Chan, CY Kuter, BJ Kaplan, KM Waters, M Kutzler, DP Carfagno, PA Sadoff, JC Heyse, JF Matthews, H Li, S Chan, ISF
Citation: Sjr. Vessey et al., Childhood vaccination against varicella: Persistence of antibody, durationof protection, and vaccine efficacy, J PEDIAT, 139(2), 2001, pp. 297-304

Authors: Heyse, JF Kaplan, KM
Citation: Jf. Heyse et Km. Kaplan, The reactogenicity and immunogenicity of commercial Haemophilus influenzaetype b conjugate vaccines, EUR J PED, 159(12), 2000, pp. 932-932

Authors: Dargan, JM Coplan, PM Kaplan, KM Nikas, A
Citation: Jm. Dargan et al., Reemergence of invasive Haemophilus influenzae type b disease in Alaska: Is it because of vaccination with polyribosylribitol phosphate outer membrane protein complex (PRP-OMPC) or failure to vaccinate with PRP-OMPC?, J INFEC DIS, 181(2), 2000, pp. 806-808
Risultati: 1-8 |